[en] Muco-cutaneous drug reactions are side effects secondary to the intake of various medications. They are quite frequent and diverse in their clinical presentation, pathogeny, histology and prognosis. It is important to diagnose and adequately monitor the disease in its early evolving phase.
Disciplines :
Dermatology
Author, co-author :
Fumal, I.
Sriha, B.
Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Lindquist M., Edwards I.R. (1993) Adverse drug reaction reporting in Europe: Some problems of comparison. Int J Risk Saf Med 4:35-46.
Mockenhaupt M., Schöpf E. (1996) Epidemiology of drug-induced severe skin reactions. Sem Cutan Med Surg 15:236-243.
Barbaud A. (1995) Place of excipients in drug related allergy. Clin Rev Allergol Immunol 13:253-263.
Paquet P. (1993) Les médicaments responsables de nécrolyse épidermique toxique (syndrome de Lyell). Therapie 48:133-139.
Piérard-Franchimont C., Henry F., Piérard G.E. Toxidermie sévère polymorphe induite par le losartan. Ann Dermatol Venereol, sous presse; .
Bigby M., Jick S., Jick H., Arndt K. (1986) Drug-induced cutaneous reactions: A report from the Boston collaborative drug surveillance program on 15438 consecutive inpatients, 1975 to 1982. JAMA 256:3358-3363.
Alanko K., Stubb S., Kauppinen K. (1989) Cutaneous drug reactions: Clinical types and causative agents. Acta Derm Venereol 69:223-226.
Tsankov N., Angelova I., Kazandjieva J. (2000) Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol 1:159-165.
Prussick R. (1996) Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy. Sem Cutan Med Surg 15:267-276.
Barbaud A., Béné M.C., Faure G. (1997) Immunological physiopathology of cutaneous adverse drug reactions. Eur J Dermatol 7:319-323.
Vaillant L. (1998) Physiopathologie des toxidermies. Ann Dermatol Venereol 125:807-815.
Merk H.F., Hertl M. (1996) Immunologic mechanisms of cutaneous drug reactions. Sem Cutan Med Surg 15:228-235.
Mauri-Hellweg D., Bettens F., Mauri D. (1995) Activation of drug-specific CD4+ and CD8+ cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155:462-472.
Barbaud A., Béné M.C., Schmutz J.L. (1997) Role of delayed cellular hypersensitivity and adhesion molecules in morbiliform rashes induced by amoxicillin. Arch Dermatol 133:481-486.
Faure G.C. (1998) Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced by antibiotics. Arch Dermatol 134:1040-1041.
Shapiro L.E., Shear N.H. (1996) Mechanisms of drug reactions: The metabolic track. Sem Cutan Med Surg 15:217-227.
Lund B.M.A., Bergan T. (1985) Temporary skin reactions to penicillins during the acute stage of infectious mononucleosis. Scand J Infect Dis 7:21-28.
Coopman S.A., Johnson R.A., Platt R., Stern R.S. (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med 328:1670-1674.
Paquet P., Piérard G.E. (1997) Erythema multiforme and toxic epidermal necrolysis. A comparative study. Am J Dermatopathol 19:127-132.
Thomine E. (1992) Variétés histologiques des toxidermies médicamenteuses. Ann Pathol 12:268-275.
Flageul B., Paul C., Wolkenstein P. (1997) Etude de l'expression des molécules médiant l'apoptose dans les toxidermies. Ann Dermatol Venereol 124.
Saxon A., Beall G.N., Rohr A.S. (1987) Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 107:204-215.
Roujeau J.C., Bioulac-Sage P., Bourseau C. (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127:1333-1338.
Beylot C., Doutre M.S., Beylot-Barry M. (1996) Acute generalized exanthematous pustulosis. Sem Cutan Med Surg 15:244-249.
Lowry M.D. (1994) Leukocytoclastic vasculitis caused by drug additives. J Am Acad Dermatol 30:854-855.
Stubb S., Alanko K., Reitamo S. (1989) Fixed drug eruptions: 77 Cases from 1981 to 1985. Br J Dermatol 120:583.
Lee A.Y. (2000) Fixed eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol 1:277-285.
Fritsch P.O., Sidoroff A. (2000) Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 1:349-360.
Revuz J., Penso D., Roujeau J.C. (1987) Toxic epidermal necrolysis: Clinical findings and prognosis factors in 87 patients. Arch Dermatol 123:1160-1165.
Hans C., Paquet P., Maréchal-Courtois C. (1993) Long-term corneal involvement following drug-induced toxic epidermal necrolysis (Lyell's disease). Ophtalmologia 206:115-118.
Paul C., Wolkenstein P., Adle H. (1996) Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134:710-714.
Paquet P., Arrese J.E., Beguin Y. Comparative pathobiology of drug induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. Current topics in pathology, Ed par R. Cerio Publ Springer Verlag. Berlin (sous presse); .
Viard F., Wehrli P., Bullani R. (1998) Inhibition of toxic epidermal necrolysis by blocade of CD95 with human intravenous immunoglobulin. Science 282:490-492.
Paquet P., Jacob G., Damas P., Piérard G.E. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns, sous presse; .
Paquet P., Nikkels A., Arrese J.E. (1994) Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 130:605-608.
Paquet P., Piérard G.E. (1998) Soluble fractions of tumor necrosis factor-a, interleukin 6 and of their receptors in toxic epidermal necrolysis. A comparison with second-degree burns. Int J Mol Med 1:459-462.
Paquet P., Paquet F., Al Saleh W. (2000) Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis. Am J Dermatopathol 22:413-417.
Hermanns-Lê T., Paquet P., Piérard-Franchimont C. (1999) Regulatory function of factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. A hypothesis. Dermatology 198:184-186.
De Weck A.L. (1991) Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol All Clin North Am 11:461-474.
Bonnetblanc J.M. (1993) Drug hypersensitivity syndrome. Dermatology 187:84-85.
Piérard G.E., Arrese J.E., Piérard-Franchimont C. (2000) Les pseudolymphomes cutanés. Rev Med Liège 55:793-797.
Boquet H., Bagot, Roujeau J.C. (1996) Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with eosinophilia and systemic symptoms: DRESS). Sem Cutan Med Surg 15:250-257.
Arrese J.E., Piérard G.E. (2000) Pourquoi faut-il traiter une onychomycose avec patience et persévérance? Comment contourner les éhecs thérapeutiques?. Rev Med Liège 55:438-442.
Barbaud A. (1998) The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 139:49-58.
Begaud B., Evreux J.C., Jouglard J., Lagier G. (1985) Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 40:111-118.
Paquet P., Piérard G.E. (1999) Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis?. Dermatology 198:198-202.
